BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7471107)

  • 1. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
    Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma.
    Laurent G; Atassi G; Hildebrand J
    Cancer Res; 1976 Nov; 36(11 Pt 1):4069-73. PubMed ID: 975049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedule-dependent potentiation of lomustine cytotoxicity by amphotericin B in mice.
    Valeriote F; Dieckman J; Chabot G
    J Natl Cancer Inst; 1986 Mar; 76(3):521-5. PubMed ID: 3456466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy.
    Tator CH
    Surg Neurol; 1977 Feb; 7(2):73-7. PubMed ID: 835077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of amphotericin B on the survival of brain-tumor-bearing mice treated with CCNU.
    Muller PJ; Tator CH
    J Neurosurg; 1978 Oct; 49(4):579-88. PubMed ID: 690687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
    Begleiter A; Lam HP; Goldenberg GJ
    Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60.
    Vertut-Croquin A; Brajtburg J; Medoff G
    Cancer Res; 1986 Dec; 46(12 Pt 1):6054-8. PubMed ID: 3465432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
    Brajtburg J; Elberg S; Schechtman KB; Medoff G
    Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of combined hyperthermia and a nitrosourea in treatment of a murine ependymoblastoma.
    Thuning CA; Bakir NA; Warren J
    Cancer Res; 1980 Aug; 40(8 Pt 1):2726-9. PubMed ID: 7388821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
    Muller PJ; Tator CH; Bloom ML
    Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of an experimental glioma with nitrosoureas.
    Tator CH; Day A; Ng R; Liberman L
    Cancer Res; 1977 Feb; 37(2):476-81. PubMed ID: 832271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy in an intracerebral murine glioma model, using Bacillus Calmette-GuĂ©rin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Albright L; Madigan JC; Gaston MR; Houchens DP
    Cancer Res; 1975 Mar; 35(3):658-65. PubMed ID: 234790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and biological distribution of radiolabeled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in an animal tumor model.
    Castronovo FP; Potsaid MS; Kopiwoda S
    Cancer Res; 1980 Oct; 40(10):3473-4. PubMed ID: 7438035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow grafts in dogs treated with lethal doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Abb J; Netzel B; Rodt HV; Thierfelder S
    Cancer Res; 1978 Jul; 38(7):2157-9. PubMed ID: 350384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site specific inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Babson JR; Reed DJ; Sinkey MA
    Biochemistry; 1977 Apr; 16(8):1584-9. PubMed ID: 856251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hirst DG; Brown JM; Hazlehurst JL
    Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins.
    Woolley PV; Dion RL; Kohn KW; Bono VH
    Cancer Res; 1976 Apr; 36(4):1470-4. PubMed ID: 4221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
    Kohlhepp SJ; May HE; Reed DJ
    Drug Metab Dispos; 1981; 9(2):135-41. PubMed ID: 6113112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.